Deaths from novel psychoactive substances in England, Wales and Northern Ireland: Evaluating the impact of the UK psychoactive substances act 2016. [PDF]
J Psychopharmacol, 2021 Background: ‘Legal highs’ began appearing in the UK in the mid-2000s. Whilst many of these substances were controlled under the 1971 Misuse of Drugs Act, novel compounds and new variants of controlled compounds were continuously being introduced to the ...
Deen AA +4 more
europepmc +2 more sources
Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review [PDF]
Brain Sciences, 2018 Recently, a range of prescription and over-the-counter drugs have been reportedly used as Novel Psychoactive Substances (NPS), due to their potential for abuse resulting from their high dosage/idiosyncratic methods of self-administration.
Fabrizio Schifano +3 more
doaj +2 more sources
Exploring the Baseline Knowledge and Experience of Healthcare Professionals in the United Kingdom on Novel Psychoactive Substances [PDF]
Brain Sciences, 2020 Objective: This survey aimed to explore knowledge and experience on novel psychoactive substances (NPS) of healthcare professionals (HCPs). The study also aimed to assess how HCPs would like to improve their knowledge of NPS.
Camille Ramos +9 more
doaj +2 more sources
Isomer-Specific Two-Color Double-Resonance IR2MS3 Ion Spectroscopy Using a Single Laser: Application in the Identification of Novel Psychoactive Substances. [PDF]
Anal Chem, 2021 The capability of an ion trap mass spectrometer to store ions for an arbitrary amount of time allows the use of a single infrared (IR) laser to perform two-color double resonance IR–IR spectroscopic experiments on mass-to-charge (m/z) selected ions.
van Geenen FAMG +5 more
europepmc +2 more sources
Novel psychoactive substances and behavioral addictions. [PDF]
Biomed Res Int, 2014 Copyright © 2014 Giovanni Martinotti et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Martinotti G +3 more
europepmc +9 more sources
Sex and Gender Differences in the Effects of Novel Psychoactive Substances. [PDF]
Brain Sci, 2020 Sex and gender deeply affect the subjective effects and pharmaco-toxicological responses to drugs. Men are more likely than women to use almost all types of illicit drugs and to present to emergency departments for serious or fatal intoxications. However, women are just as likely as men to develop substance use disorders, and may be more susceptible to
Fattore L +3 more
europepmc +7 more sources
Understanding the evolving nature of novel psychoactive substances: Mapping 10 years of research
Emerging Trends in Drugs, Addictions, and Health, 2023 Novel psychoactive substances (NPS) is an umbrella term used to describe a heterogeneous group of compounds that mimic the effects of existing drugs and whose demand and use rapidly emerge, change, or even vanish in the drug market.
Alessandro Carollo +4 more
doaj +2 more sources
Self-medication with Novel Psychoactive Substances (NPS): a Systematic Review [PDF]
International Journal of Mental Health and Addiction, 2023 Currently, novel psychoactive substance (NPS) use presents a challenging issue for authorities. To effectively tackle the use of NPS, a deeper understanding of the motivations of those who use NPS is required. Evidence suggests that a subset of NPS users
Tayler Holborn +3 more
semanticscholar +3 more sources
Analyzing the Open/Deep Web to Better Understand the New/Novel Psychoactive Substances (NPS) Scenarios: Suggestions from CASSANDRA and NPS.Finder Research Projects [PDF]
Brain Sciences, 2020 New/novel psychoactive substances (NPS) are defined as new narcotic/psychotropic drugs which are not controlled by the United Nations’ 1961 Narcotic Drugs/1971 Psychotropic Substances conventions, but which may pose a public health threat [...]
Fabrizio Schifano
doaj +2 more sources
Pharmacology of novel psychoactive substances [PDF]
, 2016 This PhD work consists of an in vitro and in vivo part. In the in vivo part, we investigated the role of dopamine in the acute clinical effects of 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) in healthy human subjects. The role of dopamine in the addictive effects of drug of abuse is well established, but whether it contributes to the acute ...
Rickli, Anna
openaire +4 more sources